COMPLETED

Tobacco Cessation at FDNY

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

At the Fire Department of the City of New York (FDNY) World Trade Center Health Program, 36% of participants in the low dose computed tomography (LDCT) lung cancer screening program are current smokers, despite referral to the free FDNY Tobacco Cessation Program (Standard Care). Investigators propose testing an Enhanced Care program which includes opt-out enrollment; tobacco cessation counseling will be individually tailored to spirometry/LDCT results and treatment with varenicline starting 4 weeks prior to their target quit date. This randomized trial will compare enrollment and cessation outcomes in Standard Care vs. Enhanced Care groups of challenging-to-treat, high-risk smokers.

Official Title

Preventing Lung Cancer Through Tobacco Cessation at FDNY

Quick Facts

Study Start:2024-05-31
Study Completion:2025-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05997225

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Shadi Nahvi, MD, MS
PRINCIPAL_INVESTIGATOR
Albert Einstein College of Medicine
David Goldfarb, PhD
PRINCIPAL_INVESTIGATOR
FDNY

Study Locations (Sites)

FDNY World Trade Center Health Program
Brooklyn, New York, 11201
United States

Collaborators and Investigators

Sponsor: Albert Einstein College of Medicine

  • Shadi Nahvi, MD, MS, PRINCIPAL_INVESTIGATOR, Albert Einstein College of Medicine
  • David Goldfarb, PhD, PRINCIPAL_INVESTIGATOR, FDNY

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-31
Study Completion Date2025-12-01

Study Record Updates

Study Start Date2024-05-31
Study Completion Date2025-12-01

Terms related to this study

Keywords Provided by Researchers

  • World Trade Center Health Program
  • occupational medicine
  • tobacco cessation
  • lifestyle medicine
  • opt-out treatment

Additional Relevant MeSH Terms

  • Tobacco Use
  • Tobacco Smoking
  • Tobacco Use Cessation